Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Bespoke Extracts, Inc.

CIK: 14091972 Annual ReportsLatest: 2025-04-21

10-K / April 21, 2025

Revenue:$1,117,452
Income:-$1,037,475

10-K / April 18, 2024

Revenue:$785,453
Income:-$1,482,843

10-K / April 21, 2025

Bespoke Extracts, Inc. Summary

Overview

Bespoke Extracts, Inc. is a Nevada corporation operating in the regulated cannabis industry through its wholly-owned subsidiary, Bespoke Extracts Colorado, LLC. The company is primarily engaged in the production, manufacturing, and distribution of cannabis consumer packaged goods, including pre-rolled marijuana cigarettes and other processed marijuana products.

Business Operations

  • Founded: Originally established in 1988, the company pivoted to cannabis operations in 2023 after acquiring a licensed adult-use marijuana-infused products business in Aurora, Colorado.
  • Key Product Categories:
    • Branded Products: Includes a variety of cannabis products under brand names such as Fresh Joints, Doobskis, DutchBlunts, and Wee Joints.
    • Processing Services: Provides processing services for licensed cultivators and dispensaries, charging a fee for each unit processed and delivered.

Customer Base

  • The company sells its products to licensed marijuana dispensaries across Colorado, indicating a focused clientele primarily in the cannabis retail sector.
  • As of March 27, 2025, the company reported approximately 1,440 holders of its common stock, excluding those holding shares in street name, suggesting a diverse base of investors and, likely, potential customers.

Financial Performance

  • Revenue:
    • For the year ended December 31, 2024, Bespoke Extracts reported revenues of $1,117,452, an increase from $785,453 the previous year.
  • Expenses:
    • Cost of products sold for 2024 was $664,517, representing around 59% of sales. This is an increase in the cost-to-sales ratio from 56% in 2023, indicating rising costs in packaging and inputs.
  • Net Loss:
    • The company incurred a net loss of $1,037,475 for the year ended December 31, 2024, compared to $1,482,843 for the prior year.
  • Working Capital:
    • As of December 31, 2024, the company held a working capital deficit of $953,414 and an accumulated deficit of $26,404,116.

Workforce

  • The company employs a total of 8 full-time employees as of the latest report date, operating with a lean staff that likely covers various roles from production to administrative functions.

Strategic Direction

  • Bespoke Extracts aims to expand its portfolio within the adult-use cannabis market, with plans for product innovation, brand building, and potential acquisitions in compliant jurisdictions.
  • The company has also discontinued activities in the CBD sector, focusing exclusively on regulated cannabis markets.

Compliance and Regulatory Landscape

  • The company complies with the stringent regulations governing the cannabis industry at both state and federal levels, while navigating the complexities associated with federal laws that classify cannabis as a Schedule I controlled substance.

This detailed summary provides an overview of Bespoke Extracts, Inc.'s operations, financials, and strategic direction in the cannabis industry as of December 31, 2024.